abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update

abrdn Life Sciences Investors (NYSE:HQL) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 18,442 shares, a drop of 70.6% from the July 15th total of 62,733 shares. Based on an average daily volume of 177,512 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.1% of the shares of the stock are sold short.

Institutional Investors Weigh In On abrdn Life Sciences Investors

Institutional investors have recently modified their holdings of the stock. Allspring Global Investments Holdings LLC increased its position in shares of abrdn Life Sciences Investors by 57.3% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 362,535 shares of the company’s stock valued at $5,898,000 after purchasing an additional 132,098 shares during the last quarter. LPL Financial LLC boosted its stake in abrdn Life Sciences Investors by 20.0% during the fourth quarter. LPL Financial LLC now owns 448,846 shares of the company’s stock worth $7,532,000 after buying an additional 74,787 shares during the period. Landscape Capital Management L.L.C. bought a new position in abrdn Life Sciences Investors during the fourth quarter valued at $1,158,000. Raymond James Financial Inc. increased its position in abrdn Life Sciences Investors by 20.3% during the second quarter. Raymond James Financial Inc. now owns 375,960 shares of the company’s stock valued at $4,816,000 after acquiring an additional 63,429 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of abrdn Life Sciences Investors by 24.5% in the third quarter. Ameriprise Financial Inc. now owns 209,681 shares of the company’s stock valued at $3,254,000 after acquiring an additional 41,255 shares during the period. 32.21% of the stock is owned by institutional investors.

abrdn Life Sciences Investors Price Performance

Shares of NYSE:HQL opened at $21.34 on Thursday. The firm has a fifty day simple moving average of $19.19 and a two-hundred day simple moving average of $17.84. abrdn Life Sciences Investors has a 52 week low of $13.44 and a 52 week high of $21.32.

abrdn Life Sciences Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Monday, August 24th will be given a $0.62 dividend. The ex-dividend date is Monday, August 24th. This represents a $2.48 annualized dividend and a yield of 11.6%.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.